Reproductive Angiogenesis in Health and Disease

Lead Research Organisation: University of Cambridge
Department Name: Obstetrics and Gynaecology

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publications

10 25 50

publication icon
Cheng CW (2008) Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. in Biochemical and biophysical research communications

publication icon
Hull ML (2008) Endometrial-peritoneal interactions during endometriotic lesion establishment. in The American journal of pathology

 
Title Mouse models of menstruation and endometriosis 
Description In the course of our basic research we have developed a new model human menstruation and a model of endometriosis. Both of these are in mice and these have furthered our understanding of endometrial function in health and disease 
Type Of Material Model of mechanisms or symptoms - mammalian in vivo 
Provided To Others? No  
Impact NA 
 
Description Bayer collaboration 
Organisation Bayer
Country Germany 
Sector Private 
PI Contribution NA
Collaborator Contribution As a result of the expertise demonstrated in our published work we have a joint project with Bayer-Schering Pharmaceuticals.
Impact NA
 
Description Pfizer collaboration 
Organisation Pfizer Ltd
Country United Kingdom 
Sector Private 
PI Contribution NA
Collaborator Contribution We already had active collaborations with Pfizer Global Research in Sandwich Kent. This has continued, (several joint papers) and we have applied for funding together. We are also negotiating the terms for a project to be funded by Pfizer and carried out in Cambridge.
Impact NA
 
Title MURINE ENDOMETRIOSIS MODELLED BY K-RAS ACTIVATION OF MENSTRUATING ENDOMETRIUM 
Description This invention relates to the production of rodent endometriosis models by implanting into wild type recipient rodents menstruating endometrium from donor rodents in which an oncogene, such as K-ras, has been activated. Rodent endometriosis models and methods of production and use of such models in screening for therapeutics are provided. 
IP Reference WO2009022119 
Protection Patent granted
Year Protection Granted 2009
Licensed Yes
Impact We have filed a patent to protect our new murine model of endometriosis. We have discussed in some depth this with 3 pharmaceutical companies and 1 in particular is particularly interested.
 
Company Name Metris Therapeutics Ltd 
Description Metris Therapeutics Ltd. was a University of Cambridge biotechnology spinoff that specializes in the research and development of medicines that treat gynecological or women's health disorders. The company is currently developing medicines to treat endometriosis, menstrual pain, and menopause symptoms. Johnson & Johnson was one of Metris' major backers. 
Impact Metris was dissolved in 2009